Due to ongoing concerns about the spread of Covid-19 all 2020 meetings have been rescheduled. Learn More


The Forbeck Foundation created a breakthrough meeting: "The Forbeck Forum" that inspires the greatest minds in medical research to find a cure for cancer. Explore our site to learn what makes the Forbeck Forums different than other cancer research meetings and conferences.

Below is a listing of past forums with summaries noted where applicable.

Leveraging Synthetic Lethality to Treat Cancer
Leveraging Synthetic Lethality to Treat Cancer

February 20–23, 2020

Chaired by:
 Carla Grandori, MD, PhD of SEngine Precision Medicine
 Christopher Kemp, PhD of Fred Hutchinson

 Sponsored by The 2019 Holiday Matching Program

  No Summary Available

View Forum

Cancer and Aging
Cancer and Aging

November 7–10, 2019

Chaired by:
 Steve Artandi, MD, PhD of Stanford University
 Marcia Haigis, PhD of Harvard Medical School

 Sponsored by The George T. Lewis Foundation

  No Summary Available

View Forum

Telomerase-Mediated Telomere Targeting in Cancer
Telomerase-Mediated Telomere Targeting in Cancer

October 17–20, 2019

Chaired by:
 Titia de Lange, PhD of Rockefeller University
 Jerry W. Shay, PhD of UT Southwestern

  Summary Available

View Forum

Scholar Retreat
Scholar Retreat

October 10–13, 2019

Chaired by:
 Chad Pecot, MD of University of North Carolina

  Summary Available

View Forum

Diffuse Intrinsic Pontine Glioma
Diffuse Intrinsic Pontine Glioma

October 3–6, 2019

Chaired by:
 Oren Becher, MD of Northwestern University
 Cynthia Hawkins MD, PhD of The Hospital for Sick Kids

 Sponsored by The Kira Spedale Foundation

  Summary Available

View Forum

Leukemia Stem Cells, Heterogeneity, and Metabolism
Leukemia Stem Cells, Heterogeneity, and Metabolism

September 12–15, 2019

Chaired by:
 Martin Carroll, MD of University of Pennsyilvania
 Craig T. Jordan, PhD of University of Colorado
 Aaron Schimmer, MD, PhD of Princess Margaret Cancer Centre

  Summary Available

View Forum

3D Chromosomal Architecture and Nuclear Topology
3D Chromosomal Architecture and Nuclear Topology

May 2–5, 2019

Chaired by:
 Ari Melnick, MD of Cornell Medical College
 Jane Skok, PhD of New York University

  Summary Available

View Forum

Cancer Predisposition
Cancer Predisposition

November 8–11, 2018

Chaired by:
 Judy E. Garber, MD, MPH of Harvard University
 John M. Maris, MD of University of Pennsylvania

  No Summary Available

View Forum

Tumor Microenvironment
Tumor Microenvironment

November 1–4, 2018

Chaired by:
 Lisa M. Coussens, PhD of Knight Cancer Institute
 Rakesh K. Jain, PhD of Massachusetts General Hospital

  No Summary Available

View Forum

Scholar Retreat
Scholar Retreat

October 11–14, 2018

Chaired by:
 Julie-Aurore Losman, MD, PhD of Dana-Farber Cancer Institute

  Summary Available

View Forum

Epigenetic Therapy
Epigenetic Therapy

September 27–30, 2018

Chaired by:
 Jean-Pierre Issa, MD of Temple University
 Stephen Baylin, MD of Johns Hopkins University
 Peter Jones, PhD of Van Andel Research Institute

  Summary Available

View Forum

Metabolic Signaling and the Epigenome
Metabolic Signaling and the Epigenome

September 13–15, 2018

Chaired by:
 Julie-Aurore Losman, MD, PhD of Dana-Farber Cancer Institute
 Kathryn Wellen, PhD of University of Pennsylvania

  Summary Available

View Forum

Convergence of Myc and Ras in Cancer
Convergence of Myc and Ras in Cancer

November 9–12, 2017

Chaired by:
 Karen Cichowski, PhD of Bringham and Women's Hospital and Harvard Medical School
 Gerard Evan PhD, FRS, FMedSci of University of Cambridge

  Summary Available

View Forum

Precision Cancer Medicine by Functional Biomarkers
Precision Cancer Medicine by Functional Biomarkers

May 19–20, 2017

Chaired by:
 Anthony Letai MD, PhD of Dana-Farber Cancer Institute

  Summary Available

View Forum

Chromosomal Instability and Aneuploidy
Chromosomal Instability and Aneuploidy

November 10–13, 2016

Chaired by:
 Angelika Amon, PhD of Massachusetts Institute of Technology
 David Pellman, MD, of Dana-Farber Cancer Institute

  No Summary Available

View Forum

Renal Medullary Carcinoma
Renal Medullary Carcinoma

April 22–23, 2016

Chaired by:
 Kimryn Rathmell MD, PhD of Vanderbilt University
 Nizar Tannir MD of MD Anderson Cancer Center

  Summary Available

View Forum

Cancer Immunotherapy
Cancer Immunotherapy

November 12–15, 2015

Chaired by:
 Catherine Bollard, MD of Washington Children’s Hospital
 Daniel Powell, PhD of University of Pennsylvania

  No Summary Available

View Forum

Invasion & Metastasis
Invasion & Metastasis

November 6–9, 2014

Chaired by:
 Ann Chambers, PhD of London Health Sciences Centre
 Zena Werb, PhD of University of California San Francisco

  Summary Available

View Forum

Extracellular Vesicles: Promises and Pitfalls
Extracellular Vesicles: Promises and Pitfalls

April 12–13, 2014

Chaired by:
 Clark C. Chen, MD, PhD of University of California San Diego

  No Summary Available

View Forum

Resistance Mechanisms
Resistance Mechanisms

November 7–10, 2013

Chaired by:
 Joan Brugge, PhD of Harvard Medical School
 Jeffrey Engelman, MD, PhD of Massachusetts General Hospital

  Summary Available

View Forum

Tumor Metabolism
Tumor Metabolism

November 1–4, 2012

Chaired by:
 Eileen White, PhD of The Cancer Institute of New Jersey
 Lewis C. Cantley, PhD of Weill Cornell Medical College

  Summary Available

View Forum

By Passing the Blood Brain Barriers to Improve Drug Delivery to Tumor in the Central Nervous System
By Passing the Blood Brain Barriers to Improve Drug Delivery to Tumor in the Central Nervous System

February 23–26, 2012

Chaired by:
 Oren Becher, MD of Duke University
 Robert Wechsler-Reya, PhD of Sanford-Burnham Institute

  No Summary Available

View Forum

Epigenetics & Drug Therapy
Epigenetics & Drug Therapy

November 3–7, 2011

Chaired by:
 Scott A. Armstrong, MD, PhD of Dana-Farber Cancer Institute
 Steven Henrikoff, PhD of Fred Hutchinson Cancer Research Center

  Summary Available

View Forum

Childhood Germ Cell Tumors: Origins, Models & New Treatment Paradigms
Childhood Germ Cell Tumors: Origins, Models & New Treatment Paradigms

March 5–7, 2011

Chaired by:
 James Amatruda, MD, PhD of UT Southwestern Medical Center
 Lindsay Frazier of Dana-Farber Cancer Institute

  Summary Available

View Forum

Cancer Genomics
Cancer Genomics

November 4–7, 2010

Chaired by:
 Richard Kolodner, PhD of University Of California, San Diego
 Michael R. Stratton, FRCPath of Sanger Institute

  No Summary Available


The Biology And Treatment Of Primary Brain Tumors
The Biology And Treatment Of Primary Brain Tumors

November 5–8, 2009

Chaired by:
 Tracy Batchelor, MD, MPH of Harvard Medical School
 Andluis F. Parada, PhD of UT Southwestern

  No Summary Available


Immunotherapy And Breaking Tolerance
Immunotherapy And Breaking Tolerance

November 6–9, 2008

Chaired by:
 James P. Allison, PhD of Memorial Sloan Kettering Cancer Center
 Stanley Riddell, MD of Fred Hutchinson Cancer Research Center

  No Summary Available


Micro RNA and Cancer
Micro RNA and Cancer

November 1–4, 2007

Chaired by:
 Carlo M. Croce, MD of The Ohio State University
 Gregory J. Hannon, PhD of Cold Spring Harbor Laboratory

  No Summary Available


Stem Cells
Stem Cells

November 2–5, 2006

Chaired by:
 John E. Dick, PhD of University Of Toronto
 David Scadden, MD of Massachusetts General Hospital

  No Summary Available


Innovations in Imaging in Cancer Research
Innovations in Imaging in Cancer Research

November 3–6, 2005

Chaired by:
 Harvey R. Herschman, PhD of UCLA
 Ralph Weissleder, MD, PhD of Massachusetts General Hospital

  No Summary Available


Molecular Targets In Pediatric Malignancies
Molecular Targets In Pediatric Malignancies

November 4–7, 2004

Chaired by:
 Gary Gilliland, MD, PhD of Howard Hughes Medical Institute
 Charles Sawyers, MD of UCLA

  No Summary Available


Fertility And Reproductive Issues In Survivors Of Childhood Cancer
Fertility And Reproductive Issues In Survivors Of Childhood Cancer

September 30–October 3, 2004

Chaired by:
 Charles Sklar, MD of Memorial Sloan Kettering Cancer Center

  No Summary Available


DNA Damage & Cancer Susceptibility Syndromes
DNA Damage & Cancer Susceptibility Syndromes

November 6–9, 2003

Chaired by:
 Alan D'andrea, MD of Dana-Farber Cancer Research Institute
 Jan Hoeijmakers of Erasmus University

  No Summary Available


The New Biology of Enigmatic Neuroblastoma and Relevant Treatment Strategies
The New Biology of Enigmatic Neuroblastoma and Relevant Treatment Strategies

March 22–23, 2003

Chaired by:
 Moritz M. Zeigler, MD of Boston Children’s Hospital

  Summary Available

View Forum

Cellular Senescence and Cancer
Cellular Senescence and Cancer

December 1, 2002

Chaired by:
 Ronald DePinho, MD of Harvard Medical School
 Charles Sherr, MD, PhD of St Jude Children’s Research Hospital

  Summary Available

View Forum

A New Tool In Cancer Medicine: Exploiting The Patient’s Immunological Memory
A New Tool In Cancer Medicine: Exploiting The Patient’s Immunological Memory

April 19–21, 2002

Chaired by:
 Philipp Beckhove of German Cancer Research Center
 Volker Schirrmacher of German Cancer Research Center

  Summary Available

View Forum

Differentiation as Cancer Therapy
Differentiation as Cancer Therapy

December 1, 2001

Chaired by:
 Raymond Paul Warrell, Jr., MD of Genta Incorporated

  Summary Available

View Forum

Mechanisms, Consequences, and Therapeutic Implications of Blood Vessel Leakiness in Cancer
Mechanisms, Consequences, and Therapeutic Implications of Blood Vessel Leakiness in Cancer

October 4–7, 2001

Chaired by:
 Donald M. McDonald, PhD of University of California San Francisco

  Summary Available

View Forum

Allogeneic Stem Cell Transplantation
Allogeneic Stem Cell Transplantation

November 1, 2000

Chaired by:
 Frederick R. Applebaum, MD of Fred Hutchinson Cancer Center

  Summary Available

View Forum

Proteases as Cancer Therapeutic Targets
Proteases as Cancer Therapeutic Targets

January 23–26, 2000

Chaired by:
 Lynn M. Matrisian, PhD of Vanderbilt University School of Medicine

  Summary Available

View Forum

Targeting Gene Therapy - A Reality?
Targeting Gene Therapy - A Reality?

December 1, 1999

Chaired by:
 John D. Minna, MD of UT Southwestern
 Inder Verma, PhD of Salk Institute

  Summary Available

View Forum

Infant Leukemia
Infant Leukemia

June 3–6, 1999

Chaired by:
 John Kersey, MD
 Norma Ramsay, MD
 Leslie L. Robinson, PhD

  No Summary Available

View Forum

Dendritic Cell Approaches to Immunotherapy
Dendritic Cell Approaches to Immunotherapy

April 1, 1999

Chaired by:
 Bruce A. Chabner, MD of National Cancer Institute

  No Summary Available


Tumor Invasion and Metastasis
Tumor Invasion and Metastasis

February 7, 1999

Chaired by:
 Arnold I. Freeman, MD of Hadassah University
 Israel Vlodavsky of Tumor Biology Research Institute

  Summary Available

View Forum

Angiogenesis and Accessibility
Angiogenesis and Accessibility

December 1, 1998

Chaired by:
 Judah Folkman, MD of Harvard Medical School
 Rakesh K. Jain, PhD of Harvard Medical School

  Summary Available

View Forum

Second Malignancies
Second Malignancies

December 1, 1997

Chaired by:
 Carlo M. Croce, MD of Jefferson Cancer Center

  Summary Available

View Forum

Specific Simple Models to Clinical Disease
Specific Simple Models to Clinical Disease

November 7–10, 1996

Chaired by:
 Richard Klausner, MD of National Cancer Institute

  Summary Available

View Forum

Apoptosis
Apoptosis

November 2–5, 1995

Chaired by:
 John T. Isaacs, PhD of Johns Hopkins University

  Summary Available

View Forum

Cell Cycle Checkpoints
Cell Cycle Checkpoints

November 3–6, 1994

Chaired by:
 Leland Hartwell, PhD of University Of Washington

  Summary Available

View Forum

Growth Factors
Growth Factors

November 4–7, 1993

Chaired by:
 John Mendelsohn, MD of Memorial Sloan Kettering Cancer Center

  Summary Available

View Forum

Gene Therapy & Tumor Vaccines
Gene Therapy & Tumor Vaccines

November 5–8, 1992

Chaired by:
 Drew Pardoll, MD, PhD of Johns Hopkins University

  Summary Available

View Forum

Dose Intensification in Pediatric Embryonal Malignancies
Dose Intensification in Pediatric Embryonal Malignancies

November 7–10, 1991

Chaired by:
 Bruce Chabner, MD of National Cancer Institute

  Summary Available

View Forum

Molecular Origins Of Pediatric Embryonal Malignancies
Molecular Origins Of Pediatric Embryonal Malignancies

November 1–4, 1990

Chaired by:
 Mark A. Israel, MD of University Of California, San Francisco

  Summary Available

View Forum

Infectious Complications
Infectious Complications

November 2–5, 1989

Chaired by:
 Philip A Pizzo, MD of National Cancer Institute

  Summary Available

View Forum

Improved Drug Delivery To Brain Tumors
Improved Drug Delivery To Brain Tumors

November 3–6, 1988

Chaired by:
 Arnold I. Freeman, MD of University Of Missouri

  Summary Available

View Forum

Reasons For Drug Failure
Reasons For Drug Failure

November 5–8, 1987

Chaired by:
 Bruce Chabner, MD of National Cancer Institute

  Summary Available

View Forum

Tumor Progression & Differentiation
Tumor Progression & Differentiation

November 6–9, 1986

Chaired by:
 Isaiah J. Fidler, DVM, PhD of MD Anderson Hospital

  Summary Available

View Forum

Neuroblastoma
Neuroblastoma

November 7–10, 1985

Chaired by:
 Arnold I. Freeman, MD of Roswell Park Memorial Institute

  Summary Available

View Forum